Wenyin Shi
Wenyin.Shi@jefferson.edu · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · Thomas Jefferson University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Wenyin Shi as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:28 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT07353229 · 68Ga-Dotatate PET and MRI Guided Radiation Dose Escalation for High Risk MeningiomaThomas Jefferson University · suspended · High Risk Meningioma, Recurrent Meningioma · principal investigator
- Ph2NCT03712904 · Stereotactic Body Radiation Therapy and Aflibercept in Treating Patients With Uveal MelanomaSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · terminated · Uveal Melanoma · principal investigator
- Early Ph1NCT03477110 · Temozolomide, Radiation Therapy, and Tumor Treating Fields Therapy in Treating Participants With GlioblastomaSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · completed · Glioblastoma · principal investigator
- N/ANCT03251027 · Intensity-Modulated Stereotactic Radiation Therapy in Treating Patients With Grade II-IV GliomaSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · active not recruiting · Glioblastoma, WHO Grade II Glioma, WHO Grade III Glioma · principal investigator
- N/ANCT03184038 · Neurocognition in Patients With Multiple Brain Metastases Treated With RadiosurgerySidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · recruiting · Metastatic Malignant Neoplasm in the Brain, Metastatic Malignant Solid Neoplasm · principal investigator
- Ph1NCT02186509 · Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade GliomasSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · completed · Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma · principal investigator
- Ph1NCT02145910 · Vemurafenib Combined With Whole Brain Radiation Therapy or Radiosurgery in Patients With BRAF Mutation-Positive Melanoma and Brain MetastasesSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · withdrawn · Recurrent Melanoma, Stage IV Melanoma, Tumors Metastatic to Brain · principal investigator
- Ph1NCT01703507 · Phase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for MelanomaSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · completed · Recurrent Melanoma, Stage IV Melanoma, Tumors Metastatic to Brain · principal investigator
- Ph1NCT01378481 · High-Dose Vorinostat and Fractionated Stereotactic Body Radiation Therapy in Treating Patients With Recurrent GliomaNational Cancer Institute (NCI) · terminated · Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma · principal investigator
- Ph1NCT01324635 · Panobinostat and Stereotactic Radiation Therapy in Treating Patients With Brain TumorsSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · terminated · Recurrent Glioma, High-grade Meningioma, Brain Metastasis · principal investigator
- Ph1NCT00838929 · Study of the Combination of Vorinostat and Radiation Therapy for the Treatment of Patients With Brain MetastasesSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · completed · Brain Metastases · principal investigator
- Ph1NCT00328575 · Using Intensity Modulated Radiation Therapy (IMRT) for Brain MetastasesSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · completed · Neoplasm Metastasis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:28 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Sidney Kimmel Cancer Center LAPS Institutional CollaborationUG1CA233341 · NCI · THOMAS JEFFERSON UNIVERSITY · fiscal years 2026 · $544,790 awarded in 2026Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Translational Research in CancerP30CA056036 · NCI · THOMAS JEFFERSON UNIVERSITY · PI Andrew Chapman · fiscal years 1999 to 2026Named on NCT01378481
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:28 UTC. The ranking covers the 200 most relevant of 269 PubMed records, and a shared surname and initials can bring in a namesake. All 269 on PubMed
- Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial.JAMA Oncol · 2020988 citationsRCR 46.6
- 883 citationsRCR 30.5
- Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer.N Engl J Med · 1999731 citationsRCR 20.1
- Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma.Nat Mater · 2017703 citationsRCR 23.2
- Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001.J Clin Oncol · 2020700 citationsRCR 35.2
- 650 citationsRCR 14.4
- Trial of Thrombectomy 6 to 24 Hours after Stroke Due to Basilar-Artery Occlusion.N Engl J Med · 2022613 citationsRCR 60.4
- Effect of Salt Substitution on Cardiovascular Events and Death.N Engl J Med · 2021602 citationsRCR 39.9
- 408 citationsRCR 19.3
- 406 citationsRCR 24.7